#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebellar ataxia Bronchopulmonary aspergillosis Myeloproliferative neoplasm Krabbe's disease Malignant neoplasm of choroid Ichthyosis Chronic granulomatous disease Colorectal cancer metastatic Sarcoidosis Immunodeficiency common variable Neutropenia Arteriovenous malformation Spina bifida Staphylococcal infection Kawasaki's disease More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma Pituitary-dependent Cushing’s syndrome – Life with Disease Hereditary motor and sensory neuropathy – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Isodicentric chromosome 15 syndrome – Life with Disease Advanced systemic mastocytosis – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Hereditary angioedema Shprintzen-Goldberg syndrome – Basic Information Rhabdomyosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Docetaxel GS-4321 Dantrolene Sodium BMS-986470 Levocarnitine Sodium Hyaluronate Etanercept Laronidase ASP3082 Berotralstat Molgramostim Keto-Isoleucine Calcium Iopromide Midodrine Hydrochloride Regorafenib Hst-1011 Rusfertide Efmoroctocog Alfa KETOROLAC TROMETAMOL Sulodexide More therapies…

    Learn about Your Condition

    Influenza Transferrin decreased Acute kidney injury Retinitis pigmentosa Cerebral palsy Sinusitis bacterial Metastases to peritoneum Electronic cigarette user Ureteric cancer Breast cancer in situ Carcinoid tumour pulmonary Hepatic encephalopathy Corneal graft failure Cardiac valve disease Type 1 diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Not recruiting

    3 1
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1

  • Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Volixibat
    Belgium France Germany Italy The Netherlands Spain

  • Study on the Safety and Effects of Riociguat for Children Aged 6 to 17 with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Riociguat
    Germany Italy

  • Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Lenalidomide
    • Obinutuzumab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Food allergy
    Investigated Drugs:
    • Defatted Powder Of Arachis Hypogaea L., Semen (Peanuts)
    • Ligelizumab
    • Salbutamol
    France Germany Italy The Netherlands Spain

  • Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cholestatic pruritus
    • Primary biliary cholangitis
    Investigated Drugs:
    • Linerixibat
    Belgium Bulgaria Czechia France Germany Greece +3

  • Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Belgium Czechia Italy Spain

  • Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    • Glomerulonephritis membranoproliferative
    Investigated Drugs:
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Pegcetacoplan
    • Pneumococcal Polysaccharide Serotype 1
    Austria Belgium Czechia France Germany Italy +2

  • Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Cladribine
    • Indometacin Ph. Eur.
    • Melphalan
    Austria Belgium Czechia Denmark Greece Ireland +6

  • Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Mecasermin Rinfabate
    Finland Germany Ireland Italy The Netherlands Portugal +1
Previous Page
1 … 38 39 40 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!